Sight Sciences Future Growth
Future criteria checks 1/6
Sight Sciences is forecast to grow earnings and revenue by 11% and 10.6% per annum respectively. EPS is expected to grow by 15.8% per annum. Return on equity is forecast to be -32.5% in 3 years.
Key information
11.0%
Earnings growth rate
15.8%
EPS growth rate
| Medical Equipment earnings growth | 17.5% |
| Revenue growth rate | 10.6% |
| Future return on equity | -32.5% |
| Analyst coverage | Good |
| Last updated | 04 Nov 2024 |
Recent future growth updates
Recent updates
Why We're Not Concerned Yet About Sight Sciences, Inc.'s (NASDAQ:SGHT) 26% Share Price Plunge
Aug 15
Is Sight Sciences (NASDAQ:SGHT) A Risky Investment?
Jul 12Sight Sciences, Inc. (NASDAQ:SGHT) Stock Catapults 46% Though Its Price And Business Still Lag The Industry
Dec 19Some Analysts Just Cut Their Sight Sciences, Inc. (NASDAQ:SGHT) Estimates
Nov 19Sight Sciences Grows Portfolio Amid Reimbursement Pressure
Aug 19Sizing Up Sight Sciences
Jun 26Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 103 | -34 | N/A | N/A | 5 |
| 12/31/2025 | 92 | -40 | N/A | N/A | 7 |
| 12/31/2024 | 82 | -49 | N/A | N/A | 7 |
| 6/30/2024 | 79 | -52 | -36 | -36 | N/A |
| 3/31/2024 | 81 | -55 | -40 | -40 | N/A |
| 12/31/2023 | 81 | -56 | -48 | -47 | N/A |
| 9/30/2023 | 83 | -62 | -57 | -56 | N/A |
| 6/30/2023 | 82 | -71 | -67 | -67 | N/A |
| 3/31/2023 | 75 | -80 | -72 | -71 | N/A |
| 12/31/2022 | 71 | -86 | -77 | -76 | N/A |
| 9/30/2022 | 65 | -85 | -72 | -71 | N/A |
| 6/30/2022 | 60 | -80 | -69 | -68 | N/A |
| 3/31/2022 | 55 | -74 | -63 | -62 | N/A |
| 12/31/2021 | 49 | -63 | -53 | -53 | N/A |
| 9/30/2021 | 43 | -56 | -51 | -50 | N/A |
| 6/30/2021 | 39 | -47 | -43 | -42 | N/A |
| 3/31/2021 | 30 | -38 | -36 | -35 | N/A |
| 12/31/2020 | 28 | -35 | -33 | -32 | N/A |
| 12/31/2019 | 23 | -26 | -26 | -25 | N/A |
| 12/31/2018 | 8 | -14 | -15 | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SGHT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SGHT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SGHT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SGHT's revenue (10.6% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: SGHT's revenue (10.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SGHT is forecast to be unprofitable in 3 years.